LAUSR

Four Ways to Limit Use of Force in Care of Persons Experiencing Homelessness.

Sign Up to like & get
recommendations!
1 Published in 2021 at "AMA journal of ethics"

DOI: 10.1001/amajethics.2021.869

Abstract: Experiencing homelessness is traumatizing and can exacerbate mental illnesses and substance use disorders. When persons experiencing homelessness are a danger to themselves or others, petitioning for involuntary placement is clinically, ethically, and legally indicated. The… read more here.

Keywords: ways limit; four ways; experiencing homelessness; use ... See more keywords

A Measured Approach to Vena Cava Filter Use-Respect Rather Than Regret.

Sign Up to like & get
recommendations!
1 Published in 2017 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2016.3882

Abstract: Is there enough evidence to support the use of inferior vena cava filters?—Yes. There is a strong effort among many physicians to avoid the use of inferior vena cava filters (IVCFs) in the treatment of… read more here.

Keywords: therapy; benefit; vena cava; use ... See more keywords

National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey

Sign Up to like & get
recommendations!
1 Published in 2017 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2016.4700

Abstract: Importance Statins remain a mainstay in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). Objective To detail the trends in use and total and out-of-pocket (OOP) expenditures associated with statins in a representative US… read more here.

Keywords: statin use; use; 2002 2013; expenditure ... See more keywords

Perspective on Trends in Statin Use.

Sign Up to like & get
recommendations!
1 Published in 2017 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2016.4710

Abstract: Since their introduction in the 1990s, statins have become the most common class of prescription medications in the United States.1 Statins work by blocking the critical pathway in the synthesis of cholesterol in the liver.… read more here.

Keywords: statin use; use; cardiology; cholesterol ... See more keywords

Effect of Baseline Nutritional Status on Long-term Multivitamin Use and Cardiovascular Disease Risk: A Secondary Analysis of the Physicians’ Health Study II Randomized Clinical Trial

Sign Up to like & get
recommendations!
0 Published in 2017 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2017.0176

Abstract: Importance Long-term multivitamin use had no effect on risk of cardiovascular disease (CVD) in the Physicians’ Health Study II. Baseline nutritional status may have modified the lack of effect. Objective To investigate effect modification by… read more here.

Keywords: multivitamin use; use; study; physicians health ... See more keywords

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

Sign Up to like & get
recommendations!
1 Published in 2018 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2018.3945

Abstract: Importance Black and Hispanic patients are less likely than white patients to use oral anticoagulants for atrial fibrillation. Little is known about racial/ethnic differences in use of direct-acting oral anticoagulants (DOACs) for atrial fibrillation. Objective… read more here.

Keywords: atrial fibrillation; fibrillation; use; oral anticoagulant ... See more keywords

Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi.

Sign Up to like & get
recommendations!
1 Published in 2020 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2020.0652

Abstract: Importance Left ventricular (LV) thrombi can arise in patients with ischemic and nonischemic cardiomyopathies. Anticoagulation is thought to reduce the risk of stroke or systemic embolism (SSE), but there are no high-quality data on the… read more here.

Keywords: use; warfarin; treatment; ventricular thrombi ... See more keywords

Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project.

Sign Up to like & get
recommendations!
0 Published in 2020 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2020.5354

Abstract: Importance After disparate results from observational and small randomized studies, the COMPLETE trial demonstrated superiority of multivessel (MV) percutaneous coronary intervention (PCI) over culprit-only PCI for ST-elevation myocardial infarction (STEMI). Objective To describe temporal trends… read more here.

Keywords: index; within days; use; quarter ... See more keywords

Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.

Sign Up to like & get
recommendations!
1 Published in 2022 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2022.2006

Abstract: Importance Dapagliflozin was shown to reduce the cardiovascular (CV) and kidney outcomes in patients with type 2 diabetes. However, data are limited on the relationship of the effect and safety with the concurrent use of… read more here.

Keywords: patients type; safety; kidney; type diabetes ... See more keywords

Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use.

Sign Up to like & get
recommendations!
1 Published in 2022 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2022.2608

Abstract: Importance In the setting of uncertain efficacy and additional, unreimbursed cost, use of an embolic protection device (EPD) during transcatheter aortic valve replacement (TAVR) has had variable uptake. The Centers for Medicare & Medicaid Services… read more here.

Keywords: new technology; reimbursement; technology add; epd use ... See more keywords

Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice.

Sign Up to like & get
recommendations!
1 Published in 2022 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2022.3839

Abstract: Importance Recent national guidelines recommend sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagonlike peptide-1 receptor agonists (GLP-1 RA) in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD); yet, there are limited data on… read more here.

Keywords: disease; use; sodium glucose; sglt2i glp ... See more keywords